Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis

Fig. 3

All-cause mortality from ILD onset in those with ILD. ILD, interstitial lung disease; PAH, pulmonary arterial hypertension; SSc, systemic sclerosis. ILD severity is defined as limited if < 20% involvement on HRCT or 20‒30% HRCT involvement with FVC ≥ 70%, or extensive if > 30% HRCT involvement, or 20‒30% HRCT involvement and FVC < 70%

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us